Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualisation of postoperative therapy.

Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualisation of postoperative therapy. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualisation of postoperative therapy. Abstract Text:

    j maedaJ Maeda,t hiranoT Hirano,a ogiwaraA Ogiwara,s akimotoS Akimoto,t kawakamiT Kawakami,y fukuiY Fukui,t okaT Oka,y gongY Gong,r guoR Guo,h inadaH Inada,k nawaK Nawa,m kojikaM Kojika,y sugaY Suga,t ohiraT Ohira,k mukaiK Mukai,h katoH Kato,j maedaJ Maeda,t hiranoT Hirano,a ogiwaraA Ogiwara,s akimotoS Akimoto,t kawakamiT Kawakami,y fukuiY Fukui,t okaT Oka,y gongY Gong,r guoR Guo,h inadaH Inada,k nawaK Nawa,m kojikaM Kojika,y sugaY Suga,t ohiraT Ohira,k mukaiK Mukai,h katoH Kato,

    Although postoperative adjuvant chemotherapy (PAC) with uracil-tegafur significantly improves the prognosis of patients with stage I lung adenocarcinoma, subset analysis has revealed that only 11.5% of patients with stage IB derive actual benefit from such therapy. Therefore, it is extremely important to identify patients for whom adjuvant chemotherapy will be beneficial. We performed comprehensive protein analysis of 24 surgically resected specimens of stage I adenocarcinoma using liquid chromatography-tandem mass spectrometry (LC-MS/MS), followed by bioinformatical investigations to identify protein molecules. Furthermore, we carried out immunohistochemical studies of 90 adenocarcinoma specimens to validate the results of LC-MS/MS. We detected two kinds of protein molecules (myosin IIA and vimentin) by LC-MS/MS. We confirmed their immunohistochemical expression and distribution, and evaluated the relationship between the expression of these proteins and prognosis after adjuvant chemotherapy. Patients with no expression of either myosin IIA or vimentin showed a significantly better outcome regardless of PAC using uracil-tegafur. However, we were unable to select responders to uracil-tegafur using these proteins. Cases of adenocarcinoma lacking expression of either myosin IIA or vimentin show a good outcome without PAC, and therefore do not require such treatment.British Journal of Cancer (2008) 98, 596-603. doi:10.1038/sj.bjc.6604197 www.bjcancer.com Published online 22 January 2008.

    Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualisation of postoperative therapy. Publishing Authors By Initials

    j maedaJ Maeda,t hiranoT Hirano,a ogiwaraA Ogiwara,s akimotoS Akimoto,t kawakamiT Kawakami,y fukuiY Fukui,t okaT Oka,y gongY Gong,r guoR Guo,h inadaH Inada,k nawaK Nawa,m kojikaM Kojika,y sugaY Suga,t ohiraT Ohira,k mukaiK Mukai,h katoH Kato,j maedaJ Maeda,t hiranoT Hirano,a ogiwaraA Ogiwara,s akimotoS Akimoto,t kawakamiT Kawakami,y fukuiY Fukui,t okaT Oka,y gongY Gong,r guoR Guo,h inadaH Inada,k nawaK Nawa,m kojikaM Kojika,y sugaY Suga,t ohiraT Ohira,k mukaiK Mukai,h katoH Kato,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualisation of postoperative therapy. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: British journal of cancer

    VOLUME: 98

    Page Numbers: 596-603

    Journal Abbreviation: Br. J. Cancer

    ISSN: 0007-0920

    DAY: 22

    MONTH: 01

    YEAR: 2008

    Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualisation of postoperative therapy. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 370635

    Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualisation of postoperative therapy. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualisation of postoperative therapy. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualisation of postoperative therapy.

    AFFILIATION: 1Department of Surgery, Tokyo Medical University, 6-7-1 Nishi-shinjuku, Shinjuku-ku, Tokyo 160-0023, Japan.

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Br J Cancer

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualisation of postoperative therapy Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News